280 related articles for article (PubMed ID: 26803345)
1. Risk factors and outcomes of cutaneous melanoma in women less than 50 years of age.
Tellez A; Rueda S; Conic RZ; Powers K; Galdyn I; Mesinkovska NA; Gastman B
J Am Acad Dermatol; 2016 Apr; 74(4):731-8. PubMed ID: 26803345
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
3. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
[TBL] [Abstract][Full Text] [Related]
4. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node biopsy in thick malignant melanoma: A 16-year single unit experience.
Hunger RE; Michel A; Seyed Jafari SM; Shafighi M
Eur J Dermatol; 2015; 25(5):472-6. PubMed ID: 26394835
[TBL] [Abstract][Full Text] [Related]
6. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
[TBL] [Abstract][Full Text] [Related]
7. Previous pregnancy is a favourable prognostic factor in women with localised cutaneous melanoma.
Vihinen P; Vainio-Kaila M; Talve L; Koskivuo I; Syrjänen K; Pyrhönen S
Acta Oncol; 2012 May; 51(5):662-8. PubMed ID: 22486294
[TBL] [Abstract][Full Text] [Related]
8. Desmoplastic and neurotropic melanoma.
Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
[TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma of the skin: long-term follow-up and time to first recurrence.
Hohnheiser AM; Gefeller O; Göhl J; Schuler G; Hohenberger W; Merkel S
World J Surg; 2011 Mar; 35(3):580-9. PubMed ID: 21125274
[TBL] [Abstract][Full Text] [Related]
10. Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study.
Hanna AN; Sinnamon AJ; Roses RE; Kelz RR; Elder DE; Xu X; Pockaj BA; Zager JS; Fraker DL; Karakousis GC
J Am Acad Dermatol; 2019 Feb; 80(2):433-440. PubMed ID: 30165160
[TBL] [Abstract][Full Text] [Related]
11. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
[TBL] [Abstract][Full Text] [Related]
12. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
[TBL] [Abstract][Full Text] [Related]
13. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
14. The effect of delay time between primary melanoma biopsy and sentinel lymph node dissection on sentinel node status, recurrence, and survival.
Parrett BM; Accortt NA; Li R; Dosanjh AS; Thummala S; Kullar R; Cleaver JE; Kashani-Sabet M; Leong SP
Melanoma Res; 2012 Oct; 22(5):386-91. PubMed ID: 22955010
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of proliferative activity and tumor stage of pregnancy-associated melanoma (PAM) and non-PAM in gestational age women.
Merkel EA; Martini MC; Amin SM; Yélamos O; Lee CY; Sholl LM; Rademaker AW; Guitart J; Gerami P
J Am Acad Dermatol; 2016 Jan; 74(1):88-93. PubMed ID: 26545488
[TBL] [Abstract][Full Text] [Related]
17. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
18. Current treatment of cutaneous melanoma and the sentinel lymph node.
Bruns SD; McGee JM; Phillips JW
J Okla State Med Assoc; 2002 May; 95(5):332-5. PubMed ID: 12043108
[No Abstract] [Full Text] [Related]
19. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.
Ellis MC; Weerasinghe R; Corless CL; Vetto JT
Am J Surg; 2010 May; 199(5):663-8. PubMed ID: 20466113
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node status predicts survival in thick melanomas: the Oxford perspective.
Rughani MG; Swan MC; Adams TS; Marshall A; Asher R; Cassell OC; Middleton MR
Eur J Surg Oncol; 2012 Oct; 38(10):936-42. PubMed ID: 22617251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
